Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 13, 2022

SELL
$126.46 - $235.05 $146,693 - $272,658
-1,160 Closed
0 $0
Q2 2021

Jul 06, 2021

BUY
$129.91 - $234.98 $150,695 - $272,576
1,160 New
1,160 $273,000
Q1 2021

Apr 15, 2021

SELL
$109.18 - $185.98 $342,279 - $583,047
-3,135 Closed
0 $0
Q4 2020

Jan 05, 2021

BUY
$65.74 - $169.86 $206,094 - $532,511
3,135 New
3,135 $328,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Enterprise Bank & Trust CO Portfolio

Follow Enterprise Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Enterprise Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Enterprise Bank & Trust CO with notifications on news.